个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Neoadjuvant short-course radiotherapy followed by camrelizumab plus chemotherapy versus long-course chemoradiotherapy followed by chemotherapy in locally advanced rectal cancer: A randomized phase III trial (UNION)

| 导出 | |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Zhang, T.[1] * ; Tao, K.[2] ; Lin, Z.[1] ; Zhang, P.[2] ; Yin, Y.[2] ; Chi, P.[3] ; Huang, Y.[3] ; Xiao, Y.[4] ; Sun, Z.[4] ; Xu, X.[5] ; Zhang, A.[6] ; Qiu, X.[7] ; Junxin, W.[8] ; Yuan, Y.[9] ; Wang, Z.[10] ; Qu, X. J.[11] ; Zhao, F.[1] ; Ma, C.[12] ; Cheng, F.[12] ; Hou, Z.[12] ;
机构： [1]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan, Peoples R China [2]Huazhong Univ Sci & Technol, Union Hosp, Dept Gastrointestinal Surg, Tongji Med Coll, Wuhan, Peoples R China [3]Fujian Med Univ Union Hosp, Dept Colorectal Surg, Fuzhou, Peoples R China [4]Peking Union Med Coll Hosp, Dept Basic Surg, Beijing, Peoples R China [5]Wuhan Univ, Ctr Canc, Renmin Hosp, Wuhan, Peoples R China [6]Hebei Univ, Dept Gastrointestinal Surg, Affiliated Hosp, Baoding, Peoples R China [7]Zhongshan Hosp Xiamen Univ, Dept Gastrointestinal Surg, Xiamen, Peoples R China [8]Fujian Canc Hosp, Radiotherapy Dept Abdominal Tumors, Fuzhou, Peoples R China [9]Zhejiang Univ, Affiliated Hosp 2, Dept Med Oncol, Sch Med, Hangzhou, Peoples R China [10]China Med Univ, Dept Surg Oncol & Gen Surg, Affiliated Hosp 1, Shenyang, Peoples R China [11]China Med Univ, Dept Med Oncol, Affiliated Hosp 1, Shenyang, Peoples R China [12]Jiangsu Hengrui Pharmaceut Co Ltd, Dept Med Affairs, Shanghai, Peoples R China
出处：
DOI： 10.1016/j.annonc.2023.10.017
ISSN：
基金：
Jiangsu Hengrui Pharmaceuticals, Shanghai, China
语种：
外文
被引次数：
WOS：
中科院(CAS)分区：
出版当年[2025]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区：
出版当年[2023]版：
Q1 ONCOLOGY
最新[2023]版：
Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者：
第一作者机构： [1]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan, Peoples R China
推荐引用方式(GB/T 7714)：
Zhang T.,Tao K.,Lin Z.,et al.Neoadjuvant short-course radiotherapy followed by camrelizumab plus chemotherapy versus long-course chemoradiotherapy followed by chemotherapy in locally advanced rectal cancer: A randomized phase III trial (UNION)[J].ANNALS OF ONCOLOGY.2023,34:S1266-S1267.doi:10.1016/j.annonc.2023.10.017.
APA：
Zhang, T.,Tao, K.,Lin, Z.,Zhang, P.,Yin, Y....&Hou, Z..(2023).Neoadjuvant short-course radiotherapy followed by camrelizumab plus chemotherapy versus long-course chemoradiotherapy followed by chemotherapy in locally advanced rectal cancer: A randomized phase III trial (UNION).ANNALS OF ONCOLOGY,34,
MLA：
Zhang, T.,et al."Neoadjuvant short-course radiotherapy followed by camrelizumab plus chemotherapy versus long-course chemoradiotherapy followed by chemotherapy in locally advanced rectal cancer: A randomized phase III trial (UNION)".ANNALS OF ONCOLOGY 34.(2023):S1266-S1267

资源点击量：15100 今日访问量：0 总访问量：960 更新日期：2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持：重庆聚合科技有限公司 地址：保定市莲池区裕华东路212号